Literature DB >> 25878634

Influence of IL-20 on lumbar disc degeneration:An experimental study.

Tianjing Yang1, Huaqing Xu2.   

Abstract

OBJECTIVE: To determine the influence of IL-20 on the development of lumbar degeneration.
METHODS: The study design was prospective and carried out in Tianjin Fourth center Hospital, Tianjin, China between Jan 2012 and Jan 2014. Sixty-nine patients with degenerative disc disease treated surgically were included in experimental group, and fifteen patients with normal discs were included in control group. The evaluation of disc degeneration was performed using T2-weighted sagittal MRI according to the Modified Pfirrmann Grading System. After surgery, the intervertebral disc in both groups was collected and the content of proteoglycan and IL-20 were measured, the correlation between the content of IL-20, proteoglycan and the degeneration grade of lumbar disc was analyzed.
RESULTS: Compared to control group, the content of proteoglycan in experimental group is significantly lower (P=0.000), but IL-20 is significantly higher (P=0.001). In addition, with the advance of intervertebral disc degeneration, the content of IL-20 increase, while proteoglycan decrease gradually. There is significant correlation between the content of proteoglycan (p=0.001), IL-20 (p=0.002) and the degeneration grade of lumbar disc.
CONCLUSION: In patients with degenerative disc disease, the content of IL-20 and proteoglycan has significant correlation with degeneration grade of lumbar disc, and IL-20 may promote the degeneration of lumbar disc by affecting the synthesis of proteoglycan.

Entities:  

Keywords:  IL-20; Lumbar degeneration; Modified Pfirrmann Grading System; Proteoglycan

Year:  2015        PMID: 25878634      PMCID: PMC4386177          DOI: 10.12669/pjms.311.5720

Source DB:  PubMed          Journal:  Pak J Med Sci        ISSN: 1681-715X            Impact factor:   1.088


INTRODUCTION

Low back pain is one of the most common disease in the world and about 60% to 80% of the United States population have experienced low back pain during their lives.[1] Most of low back pain can be attributed to the degenerative disc disease (DDD). Many factors have influence on the degenerative progress of lumbar intervertebral disc. The biomechanical factors play an important role,[2] and the abnormal stress in intervertebral disc may result in the minor injury in annulus fibrosus, inducing immune and inflammatory reaction in nucleus pulposus, and lead to the production of inflammatory factors,[3]-[5] such as IL-1β, TNF-α and NO, which inhibit the synthesis of proteoglycan, and aggravate the degeneration of intervertebral disc. Many studies have been performed on the inflammation factors in degenerative intervertebral discs. In a study on twenty consecutive patients, Huang concluded IL-20 induces proinflammatory, chemotaxtic, and matrix degradative responses in the intervertebral disc, suggesting IL-20 plays a critical role in the pathogenesis of disc herniation.[6] In addition, IL-20 is also involved in inflammatory diseases such as psoriasis, atherosclerosis, and rheumatoid arthritis, indicating IL-20 is an important inflammation factor correlated to the chronical bone and joint disease. Subsequently, we assumed IL-20 may aggravate the degeneration of lumbar disc by affecting the synthesis of proteoglycan, and the advance of lumbar disc degeneration may result in the increased expression of IL-20. While, no correlated studies have been published in English literatures. Therefore, we carried out a comparative investigation on the content of IL-20 and proteoglycan in lumbar disc of patients with DDD and without. The objective of this study was to detect the correlation between IL-20 and the degeneration grade of lumbar disc, analyze the influence of IL-20 on the development of intervertebral disc degeneration.

METHODS

The study was prospective and carried out in Tianjin Fourth center Hospital, Tianjin, China between Jan 2012 and Jan 2014. The patients with DDD treated surgically in spine department of our hospital during this period were included in experimental group if they met the inclusion criteria: (1) Patients with DDD; (2) The diagnosis of DDD was confirmed by symptoms, physical examination and magnetic resonance imaging (MRI). However, the patients with previous spine surgeries, concomitant scoliosis, lumbar spine fracture, lumbar instability, spondylolisthesis, spondylosis, tumors or metastatic tumors, iatrogenic abnormality, and the patients with more than one lumbar segment treated surgically were excluded. In addition, the patients with spinal fractures treated during the same period were included in control group. To facilitate a comparative study, the participants in the control group were all young patients, which were treated surgically using anterior corpectomy. The study was approved by the ethics committee of our hospital, all the participants gave a written informed consent. Each participant in experimental group received MRI before surgery. The evaluation of lumbar intervertebral disc degeneration was carried out using the T2-weighted sagittal MRI according to the Modified Pfirrmann Grading System (Table-I).[7] The grade of disc degeneration was determined by assessing the signal intensity of the intervertebral disc and disc space height. Grade 1 indicated normal disc and grade 8 the most severest degeneration.[7]
Table-I

Modified Grading System for Lumbar Disc Degeneration

Grade Signal From Nucleus and Inner Fibers of Anulus Distinction Between Inner and Outer Fibers of Anulus at Posterior Aspect of Disc Disc Height
1Uniformly hyperintense, equal to CSFDistinctNormal
2Hyperintense (>presacral fat and <CSF)±hypointense intranuclear cleftDistinctNormal
3Hyperintense though < presacral fatDistinctNormal
4Mildly hyperintense (slightly>outer fibers of anulus)IndistinctNormal
5Hypointense (= outer fibers of anulus)IndistinctNormal
6HypointenseIndistinct<30% reduction
7HypointenseIndistinct30%–60% reduction
8HypointenseIndistinct>60% reduction
Immunohistochemistry was performed on the fresh specimens of nucleus pulposus following surgery. The content of proteoglycan was measured using the dimethyllmethylene blue dye binding assay.[8] The level of IL-20 was measured by enzyme-linked immunosorbent assay using commercially available detection kits (Adiponectin: Fenyu Biotech, Shenzhen, China) according to the manufacture’s protocol.[6] Statistical analysis was carried out using SPSS 17.0 software. The comparison of the contents of proteoglycan and IL-20 between two groups was performed using One-Way ANOVA. The correlation between the content of IL-20, proteoglycan and the grade of disc degeneration was evaluated using Spearman’s correlation analysis. A p-value of less than 0.05 was considered statistical significance.

RESULTS

Sixty-nine patients with degenerative disc disease participated this study, which included twenty-two females and forty-seven males. The mean age was 49.8 years (ranged from 28 to 74 years). Among 69 cases, 24 were lumbar stenosis, 18 were discogenic pain and 27 were lumbar disc herniation. According to the Modified Pfirrmann Grading System, there were 11 cases in Grade 3, 16 in Grade 4, 12 in grade 5, 21 in Grade 6, 9 in Grade 7 and no case in Grade 1, Grade 2 or Grade 8. All the patients were treated surgically and the operated levels were L4-L5 in 39 cases, L5-S1in 30 cases, among which lumbar discectomy was performed in 25 cases, posterior lumbar interbody fusion in 30 cases, intervertebral disk replacement in 6 cases and transforaminal lumbar interbody fusion in 8 cases. Fifteen patients with spinal fractures were included in the control group. There were thirteen males and two females. All the fifteen patients had magnetic resonance images, which confirm their discs were not herniated, degenerated, or otherwise injured by the fracture. The average age in the control group was 27.5 years, ranging from 19 to 31 years. The content of IL-20 and proteoglycan in two groups was listed in Table-II. Compared to control group, the content of proteoglycan is significantly lower (P=0.00), but the content of IL-20 is significantly higher (P=0.01) in specimen group. In addition, with the advance of disc degeneration, the content of IL-20 increase, but proteoglycan decrease gradually (Table-III). The statistical analysis indicate there is significant correlation between the content of proteoglycan (p=0.001) or IL-20 (p=0.002) and the degeneration grade of lumbar intervertebral discs.
Table-II

The content of IL-20 and proteoglycan in two groups

Group Number IL-20 (pg/ml) Proteoglycan (mg/g)
Experimental group6962.45±9.1856.78±11.03
Control group1519.26±7.86182.45±23.91
p-value0.0010.000
Table-III

The content of IL-20 and proteoglycan in different grade of disc degeneration

Grade n IL-20 Proteoglycan
31157.96±9.8671.66±10.04
41658.84±7.2165.72±9.83
51260.19±8.3260.86±7.53
62162.56±6.2044.23±7.45
7964.27±9.1738.57±6.18

DISCUSSION

In the present study, we detected the correlation between IL-20 and the degeneration of lumbar disc, analyze the influence of IL-20 on the development of lumbar degeneration. Up to now, no studies have been published on the subject in English literatures. The proteoglycan in intervertebral disc is responsible for the swelling behaviors, streaming potential, and compressive properties of the tissue, which may affect the mechanical properties of intervertebral disc.[9] Breakdown of the large aggregating proteoglycans result in the reduction of capacity of nucleus pulposus, leading to a loss of disc hydration and decreased hydrostatic pressure. Ultimately, degeneration progresses to decreased disc height, structural changes in annulus fibrosus, annular tears and the formation of osteophytes.[10] As a result, a loss of proteoglycans in nucleus pulposus is regarded as a clear sign of early degeneration.[9] In the present study, compared to the control group, the content of proteoglycan in degenerative discs in experimental group decreased significantly. Moreover, the content of proteoglycan decreased with the advance of disc degeneration, and the content of proteoglycan correlated significantly with the degeneration grade of lumbar disc, indicating proteoglycan is the important sign of disc degeneration, and our results confirmed the above mentioned viewpoints. In terms of the mechanism of intervertebral disc degeneration, inflammation mechanism was highlighted in recent years, and inflammatory factors, including interleukin, tumor necrosis factors and nitrogen monoxide, have been proved to play an important role in the process of intervertebral disc degeneration. IL-20 belongs to the IL-10 family, expressed in monocytes, epithelial, and endothelial cells, and is involved in the onset and progression of many inflammatory diseases.[11] Tritsaris et al. found that in a rat ischemic hind-limb model, IL-20 can significantly promote reestablishment of collateral networks and blood perfusion in the ischemic skeletal muscle tissue.[12] In a study on twenty consecutive patients with intervertebral disc herniation, Huang found that IL-20 and its receptors were detectable in human herniated disc tissues and isolated disc cells, suggesting the expression and secretion of IL-20 acts in an autocrine manner to modulate inflammatory reaction and angiogenesis, and concluded IL-20 played an important role in the pathogenesis of disc degeneration.[6] In the current study, we found the content of IL-20 in the experimental group was significantly higher than those in the control group, which confirmed Huang’s conclusion, and subsequently, we supported the viewpoint that IL-20 play an important role in the development of intervertebral disc degeneration. At the same time, we found with the advance of disc degeneration, the content of IL-20 increase, but proteoglycan decrease gradually, indicating IL-20 was significantly correlated with the degeneration grade of intervertebral discs. In addition, the process of IL-20 affecting the disc degeneration may be correlated closely with proteoglycan. The abnormal stress in lumbar disc level may cause the production of minor fissures, which then induce immune or inflammatory reaction and increase the contents of inflammatory factors in annulus fibrosus.[3]-[5] As IL-20 is an arteriogenic cytokine[12], in the process of disc degeneration, IL-20 may promote the vascular growth into the fissure of annulus, promote the degradation of matrix, affect the synthesis of proteoglycan and aggravate the degeneration of intervertebral disc. Modified Grading System for Lumbar Disc Degeneration The content of IL-20 and proteoglycan in two groups The content of IL-20 and proteoglycan in different grade of disc degeneration In conclusion, we found in this study IL-20 correlated closely with the degeneration grade of intervertebral disc in DDD patients. However, the current study has its limitation, we focused on the correlation between IL-20 and degeneration grade of lumbar discs, but its detailed mechanism and process were complicated and still unclear. Hence, more studies need to be performed in the future to find out its mechanism.
  12 in total

1.  The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration.

Authors:  J Antoniou; T Steffen; F Nelson; N Winterbottom; A P Hollander; R A Poole; M Aebi; M Alini
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

2.  Does anterior lumbar interbody fusion promote adjacent degeneration in degenerative disc disease? A finite element study.

Authors:  Shujie Tang; Brandon J Rebholz
Journal:  J Orthop Sci       Date:  2011-02-11       Impact factor: 1.601

Review 3.  IL-20: biological functions and clinical implications.

Authors:  Chi-Chen Wei; Yu-Hsiang Hsu; Hsing-Hui Li; Yo-Ching Wang; Mei-Yi Hsieh; Wei-Yu Chen; Chung-Hsi Hsing; Ming-Shi Chang
Journal:  J Biomed Sci       Date:  2006-05-16       Impact factor: 8.410

4.  Measurements of proteoglycan and water content distribution in human lumbar intervertebral discs.

Authors:  James C Iatridis; Jeffrey J MacLean; Mary O'Brien; Ian A F Stokes
Journal:  Spine (Phila Pa 1976)       Date:  2007-06-15       Impact factor: 3.468

Review 5.  The cell biology of intervertebral disc aging and degeneration.

Authors:  Chang-Qing Zhao; Li-Min Wang; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Ageing Res Rev       Date:  2007-08-10       Impact factor: 10.895

6.  IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs.

Authors:  Katerina Tritsaris; Maja Myren; Sisse B Ditlev; Martin V Hübschmann; Ida van der Blom; Anker Jon Hansen; Uffe B Olsen; Renhai Cao; Junhang Zhang; Tanghong Jia; Eric Wahlberg; Steen Dissing; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

Review 7.  The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain.

Authors:  A J Freemont
Journal:  Rheumatology (Oxford)       Date:  2008-10-14       Impact factor: 7.580

8.  Modified Pfirrmann grading system for lumbar intervertebral disc degeneration.

Authors:  James F Griffith; Yi-Xiang J Wang; Gregory E Antonio; Kai Chow Choi; Alfred Yu; Anil T Ahuja; Ping Chung Leung
Journal:  Spine (Phila Pa 1976)       Date:  2007-11-15       Impact factor: 3.468

9.  Biologic response of the intervertebral disc to static and dynamic compression in vitro.

Authors:  Dong-Liang Wang; Sheng-Dan Jiang; Li-Yang Dai
Journal:  Spine (Phila Pa 1976)       Date:  2007-11-01       Impact factor: 3.468

10.  IL-20 may contribute to the pathogenesis of human intervertebral disc herniation.

Authors:  Kuo-Yuan Huang; Ruey-Mo Lin; Wei-Yu Chen; Chia-Lin Lee; Jing-Jou Yan; Ming-Shi Chang
Journal:  Spine (Phila Pa 1976)       Date:  2008-09-01       Impact factor: 3.468

View more
  1 in total

1.  Long non-coding RNA zinc finger antisense 1 expression associates with increased disease risk, elevated disease severity and higher inflammatory cytokines levels in patients with lumbar disc degeneration.

Authors:  Ruo-Yu Deng; Tian Hong; Chun-Ying Li; Chun-Li Shi; Cheng Liu; Fang-Yu Jiang; Jun Li; Xiao-Man Fan; Shuang-Bing Feng; Yi-Fan Wang
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.